AbCellera Biologics (ABCL) Income Statement (2020 - 2026)
Income Statement report data from Mar 31, 2020 to Mar 31, 2026 for AbCellera Biologics (ABCL).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||
Total Revenue | 8.32M (-81.45%) | 45M (+400.56%) | 8.96M (-47.54%) | 17M (+302.83%) | 4.24M (-16.04%) | 5.05M (-22.43%) | 6.51M (-11.07%) | 7.32M (-26.43%) | 9.95M (+8.39%) | 9.18M (+39.09%) | 6.60M (-34.39%) | 10M (-17.47%) | 12M (-43.41%) | 22M (-78.75%) | 101M (+120.78%) | 46M (-85.49%) | 317M (+127.25%) | 139M (+2428.31%) | 5.51M (-80.07%) | 28M (-86.37%) | 203M (-2.49%) | 208M (+2121.26%) | 9.36M (-16.65%) | 11M (+140.99%) | 4.66M |
Operating Expenses | |||||||||||||||||||||||||
Research And Development | 47M (-6.85%) | 50M (-8.98%) | 55M (+40.35%) | 39M (-7.74%) | 43M (-7.77%) | 46M (+12.47%) | 41M (+0.10%) | 41M (+4.17%) | 39M (-19.19%) | 49M (+28.22%) | 38M (+3.98%) | 36M (-30.73%) | 53M (+86.37%) | 28M (+6.28%) | 27M (-0.41%) | 27M (+1.21%) | 26M (+53.22%) | 17M (-1.38%) | 17M (+15.95%) | 15M (+21.86%) | 12M (+42.94%) | 8.64M (+15.20%) | 7.50M (-17.94%) | 9.14M (+121.84%) | 4.12M |
Selling General And Administrative | 12M (-46.69%) | 23M (+4.90%) | 22M (+16.17%) | 19M (-0.47%) | 19M (-33.78%) | 29M (+50.39%) | 19M (-5.15%) | 20M (+16.37%) | 17M (-42.47%) | 30M (+109.88%) | 14M (-7.41%) | 16M (+2.58%) | 15M (+16.30%) | 13M (-5.66%) | 14M (-4.30%) | 14M (+0.98%) | 14M (+10.19%) | 13M (+14.91%) | 11M (+0.63%) | 11M (+74.45%) | 6.42M (+10.88%) | 5.79M (+94.95%) | 2.97M (+98.00%) | 1.50M (-9.09%) | 1.65M |
Operating Expenses | 66M (-10.35%) | 73M (-13.84%) | 85M (+27.84%) | 67M (-0.34%) | 67M (-14.01%) | 78M (-22.33%) | 100M (-0.61%) | 101M (+55.40%) | 65M (-13.80%) | 75M (+22.35%) | 61M (+0.07%) | 61M (-20.27%) | 77M (+29.92%) | 59M (-6.80%) | 64M (+17.20%) | 54M (-40.73%) | 92M (+58.42%) | 58M (+72.14%) | 34M (-3.11%) | 35M (-22.36%) | 45M (-5.22%) | 47M (+323.45%) | 11M (-7.86%) | 12M (+78.17%) | 6.78M |
Depreciation And Amortization | 6.84M (+186.19%) | 2.39M (-54.48%) | 5.25M (-4.02%) | 5.47M (+2.63%) | 5.33M | -65.75M | 37M (+1.10%) | 37M (+654.55%) | 4.84M (-35.81%) | 7.54M (+31.36%) | 5.74M (+2.32%) | 5.61M (+1.81%) | 5.51M (-60.13%) | 14M (+168.35%) | 5.15M (+5.32%) | 4.89M (+22.56%) | 3.99M (+0.76%) | 3.96M (+7.90%) | 3.67M (+4.26%) | 3.52M (+6.34%) | 3.31M (-0.60%) | 3.33M (+8225.00%) | 40K (-95.51%) | 890K (+56.14%) | 570K |
Operating Income | |||||||||||||||||||||||||
Operating Income | -57.52M (+101.26%) | -28.58M (-62.53%) | -76.28M (+53.85%) | -49.58M (-20.87%) | -62.66M (-13.87%) | -72.75M (-22.33%) | -93.66M (+0.22%) | -93.45M (+70.25%) | -54.89M (-16.90%) | -66.05M (+20.33%) | -54.89M (+6.81%) | -51.39M (-20.78%) | -64.87M (+71.70%) | -37.78M | 38M | -8.40M | 225M (+176.11%) | 81M | -28.10M (+299.72%) | -7.03M | 158M (-1.69%) | 161M | -1.77M (+108.24%) | -850.00K (-59.91%) | -2.12M |
Ebit | -57.52M (+101.26%) | -28.58M (-62.53%) | -76.28M (+53.85%) | -49.58M (-20.87%) | -62.66M (-13.87%) | -72.75M (-22.33%) | -93.66M (+0.22%) | -93.45M (+70.25%) | -54.89M (-16.90%) | -66.05M (+20.33%) | -54.89M (+6.81%) | -51.39M (-20.78%) | -64.87M (+71.70%) | -37.78M | 38M | -8.40M | 225M (+176.11%) | 81M | -28.10M (+299.72%) | -7.03M | 158M (-1.69%) | 161M | -1.77M (+108.24%) | -850.00K (-59.91%) | -2.12M |
EBITDA | -50.68M (+93.51%) | -26.19M (-63.13%) | -71.03M (+61.03%) | -44.11M (-23.06%) | -57.33M (-58.61%) | -138.50M (+144.10%) | -56.74M (-0.33%) | -56.93M (+13.75%) | -50.05M (-14.47%) | -58.52M (+19.06%) | -49.15M (+7.36%) | -45.78M (-22.88%) | -59.36M (+147.75%) | -23.96M | 43M | -3.51M | 229M (+167.99%) | 85M | -24.43M (+596.01%) | -3.51M | 161M (-1.66%) | 164M | -1.73M | 40K | -1.55M |
Other Income / Expenses | |||||||||||||||||||||||||
Interest Income | 3.64M (-56.92%) | 8.45M (+24.82%) | 6.77M (-10.80%) | 7.59M (+37.50%) | 5.52M (-36.33%) | 8.67M (-9.69%) | 9.60M (-2.04%) | 9.80M (-5.77%) | 10M (-5.20%) | 11M (+2.14%) | 11M (-0.37%) | 11M (+10.45%) | 9.76M (+15.64%) | 8.44M (+51.80%) | 5.56M (+294.33%) | 1.41M (+110.45%) | 670K (-79.88%) | 3.33M | - | - | - | 290K | - | - | - |
Net Interest Income | 3.64M (-56.92%) | 8.45M (+24.82%) | 6.77M (-10.80%) | 7.59M (+37.50%) | 5.52M (-36.33%) | 8.67M (-9.69%) | 9.60M (-2.04%) | 9.80M (-5.77%) | 10M (-5.20%) | 11M (+2.14%) | 11M (-0.37%) | 11M (+10.45%) | 9.76M (+15.64%) | 8.44M (+51.80%) | 5.56M (+294.33%) | 1.41M (+110.45%) | 670K (-79.88%) | 3.33M | - | - | - | 290K | - | - | - |
Other Non Operating Income | 7.98M | -2.71M (+36.87%) | -1.98M | 1.96M | -2.53M | 62M (+247.16%) | 18M (-44.22%) | 32M | -1.53M | 6.78M (+230.73%) | 2.05M | -1.97M | 3.59M | -4.04M | 1.15M | -1.44M | - | -6.08M (+382.54%) | -1.26M | 310K (+14.81%) | 270K | -6.81M (+201.33%) | -2.26M (+679.31%) | -290.00K (-71.00%) | -1.00M |
Net Income | |||||||||||||||||||||||||
Income Before Tax | -49.54M (+154.05%) | -19.50M (-71.64%) | -68.77M (+89.24%) | -36.34M (-31.41%) | -52.98M (+13.13%) | -46.83M (-25.23%) | -62.63M (+29.96%) | -48.19M (+12.73%) | -42.75M (-12.04%) | -48.60M (+23.73%) | -39.28M (+3.37%) | -38.00M (-21.08%) | -48.15M (+53.30%) | -31.41M | 47M | -6.89M | 231M (+172.47%) | 85M | -24.97M (+1106.28%) | -2.07M | 161M (+3.57%) | 156M | -2.69M | 6.70M | -2.09M |
Income Tax Expense | -6.37M (-39.62%) | -10.55M (-9.44%) | -11.65M (+619.14%) | -1.62M (-77.99%) | -7.36M (-41.68%) | -12.62M (+9.55%) | -11.52M (+2.31%) | -11.26M (+426.17%) | -2.14M (+47.59%) | -1.45M (-86.41%) | -10.67M (+42.65%) | -7.48M (-6.97%) | -8.04M (+428.95%) | -1.52M | 20M | -100.00K | 62M (+151.37%) | 25M | -3.59M | 250K (-99.44%) | 44M (+13.75%) | 39M | - | - | - |
Net Income From Continuing Operations | -43.16M (+382.77%) | -8.94M (-84.35%) | -57.12M (+64.47%) | -34.73M (-23.87%) | -45.62M (+33.35%) | -34.21M (-33.07%) | -51.11M (+38.40%) | -36.93M (-9.06%) | -40.61M (-13.87%) | -47.15M (+64.80%) | -28.61M (-6.29%) | -30.53M (-23.88%) | -40.11M (+34.19%) | -29.89M | 27M | -6.78M | 169M (+181.18%) | 60M | -21.38M (+821.55%) | -2.32M | 117M (+0.19%) | 117M | -2.69M | 6.70M | -2.09M |
Net Income | -43.16M (+382.77%) | -8.94M (-84.35%) | -57.12M (+64.47%) | -34.73M (-23.87%) | -45.62M (+33.35%) | -34.21M (-33.07%) | -51.11M (+38.40%) | -36.93M (-9.06%) | -40.61M (-13.87%) | -47.15M (+64.80%) | -28.61M (-6.29%) | -30.53M (-23.88%) | -40.11M (+34.19%) | -29.89M | 27M | -6.78M | 169M (+181.18%) | 60M | -21.38M (+821.55%) | -2.32M | 117M (+0.19%) | 117M | -2.69M | 6.70M | -2.09M |
Comprehensive Income Net Of Tax | -41.35M (-71.73%) | -146.27M (+155.90%) | -57.16M (+88.09%) | -30.39M (-37.00%) | -48.24M (-70.85%) | -165.51M (+229.24%) | -50.27M (+35.17%) | -37.19M (-8.65%) | -40.71M (-72.26%) | -146.73M (+420.87%) | -28.17M (-7.37%) | -30.41M (-25.36%) | -40.74M | 157M (+519.23%) | 25M | -7.00M | 169M (+9.98%) | 154M | -22.89M (+13364.71%) | -170.00K | 117M (-1.43%) | 119M | -2.69M | 6.70M | - |